New norovirus vaccine approach may help treat other RNA viruses
Base to Base biotech podcast 72: Cell-free DNA bioproduction
KTU chemists develop dual-action compounds to fight cancer
RSV antiviral drug receives FDA approval for phase II trial
ten23 health obtains Swissmedic licences for Basel and Visp facilities
SK bioscience launches initiative to reduce uncertainty in vaccine-development decisions
Human embryo gene-correction research approved
New immunotherapy strategy targets aggressive brain tumours and their fuel
New tool gives scientists clearer view of DNA regulation
Base to Base biotech podcast 66: The future of clinical trials and breakthroughs in molecular testing
Fast Track Designation for epidermolysis bullosa simplex treatment
Enzyme evolves into ‘control switch’ to reveal new TB weak spot